Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $597.50 | 2 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $597.50 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $597.50 | 2 | AstraZeneca Pharmaceuticals LP ($597.50) |
All Payment Transactions
2 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2019 | AstraZeneca Pharmaceuticals LP | — | — | In-kind items and services | $35.00 | Research |
| Study: MEDI9447 CD73 Solid Tmr-D6070C00001 Phase 1 Clinical Trial | ||||||
| 04/23/2019 | AstraZeneca Pharmaceuticals LP | — | — | Cash or cash equivalent | $562.50 | Research |
| Study: MEDI9447 CD73 Solid Tmr-D6070C00001 Phase 1 Clinical Trial | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| MEDI9447 CD73 Solid Tmr-D6070C00001 Phase 1 Clinical Trial | AstraZeneca Pharmaceuticals LP | $597.50 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 408 | 863 | $234,477 | $65,603 |
| 2022 | 4 | 352 | 829 | $233,582 | $63,897 |
| 2021 | 4 | 427 | 961 | $270,880 | $74,848 |
| 2020 | 4 | 547 | 1,283 | $388,860 | $90,256 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 90 | 150 | $52,500 | $14,624 | 27.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 80 | 207 | $50,715 | $14,190 | 28.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 73 | 140 | $49,000 | $13,832 | 28.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 172 | $42,140 | $11,697 | 27.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 39 | 39 | $18,720 | $5,169 | 27.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 23 | 23 | $11,040 | $3,049 | 27.6% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2023 | 28 | 77 | $6,045 | $1,774 | 29.4% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 20 | 55 | $4,318 | $1,267 | 29.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 80 | 241 | $60,255 | $16,629 | 27.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 94 | 169 | $59,990 | $16,508 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 52 | 194 | $48,770 | $12,963 | 26.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 68 | 129 | $45,890 | $12,921 | 28.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 14 | 14 | $6,900 | $1,656 | 24.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 13 | 13 | $6,360 | $1,629 | 25.6% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2022 | 16 | 36 | $2,826 | $830.88 | 29.4% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 15 | 33 | $2,591 | $760.80 | 29.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 98 | 298 | $75,990 | $20,753 | 27.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 91 | 162 | $58,320 | $16,895 | 29.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 68 | 213 | $54,315 | $14,800 | 27.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 87 | 149 | $53,640 | $14,609 | 27.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 22 | 22 | $11,000 | $2,877 | 26.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 20 | 20 | $10,000 | $2,605 | 26.1% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2021 | 22 | 49 | $3,847 | $1,204 | 31.3% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2021 | 19 | 48 | $3,768 | $1,106 | 29.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 97 | 442 | $112,710 | $26,102 | 23.2% |
About Dr. Jean Grem, MD
Dr. Jean Grem, MD is a Hematology & Oncology healthcare provider based in Omaha, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609824424.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jean Grem, MD has received a total of $597.50 in payments from pharmaceutical and medical device companies, with $597.50 received in 2019. These payments were reported across 2 transactions from 1 company. The most common payment nature is "" ($597.50).
As a Medicare-enrolled provider, Grem has provided services to 1,734 Medicare beneficiaries, totaling 3,936 services with total Medicare billing of $294,604. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Omaha, NE
- Active Since 05/04/2006
- Last Updated 06/22/2011
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1609824424
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Omaha
James Armitage, Md, MD
Hematology & Oncology — Payments: $1.5M
Margaret Block, M.d, M.D
Hematology & Oncology — Payments: $444,214
Julie Vose, Md, MD
Hematology & Oncology — Payments: $194,187
Peter Silberstein, M.d, M.D
Hematology & Oncology — Payments: $143,878
Apar Kishor Ganti, Md, MD
Hematology & Oncology — Payments: $135,871
Dr. Krishna Gundabolu, M.d, M.D
Hematology & Oncology — Payments: $75,519